Localization of Therapeutic Fab-CHP Conjugates to Sites of Denatured Collagen for the Treatment of Rheumatoid Arthritis
0 Comments
In a recently accepted article published in Bioconjugate Chemistry, researchers from the University of Utah used CHPs in an antibody-conjugate to address Rheumatoid Arthritis(RA). In this paper, the authors used the Fab region from infliximab (an anti-TNFα therapy known as Remicade®) and conjugated this with CHPs. Figure Caption. A) Biodistribution of IR680 labeled bFab-(NIRF)CHP...
View Details
Intracellular Hydroxyproline Imprinting Following Resolution of Bleomycin-induced Pulmonary Fibrosis
0 Comments
Dr. Yong-Su Jin's research on Intracellular Hydroxyproline Imprinting explores collagen synthesis and degradation in resolving bleomycin-induced pulmonary fibrosis. Using CHPs, the study challenges conventional theories, suggesting that fibrosis can self-resolve, contrary to high hydroxyproline levels imply.
View Details